KFD

N-[2-(morpholin-4-yl)-6-(piperidin-1-yl)-1,3-benzoxazol-5-yl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyridine-2-carboxamide

Created:	2018-11-30
Last modified:	2018-12-12

Find Related PDB Entry
1 entries where KFD is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	0
Bond Count	74
Aromatic Bond Count	26

2D diagram of KFD

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[2-(morpholin-4-yl)-6-(piperidin-1-yl)-1,3-benzoxazol-5-yl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyridine-2-carboxamide
Systematic Name (OpenEye OEToolkits)	~{N}-(2-morpholin-4-yl-6-piperidin-1-yl-1,3-benzoxazol-5-yl)-6-(1~{H}-pyrrolo[2,3-b]pyridin-5-yl)pyridine-2-carboxamide
Formula	C₂₉ H₂₉ N₇ O₃
Molecular Weight	523.586
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1CCCCN1c4cc3oc(N2CCOCC2)nc3cc4NC(=O)c5nc(ccc5)c7cc6ccnc6nc7
SMILES	CACTVS	3.385	O=C(Nc1cc2nc(oc2cc1N3CCCCC3)N4CCOCC4)c5cccc(n5)c6cnc7[nH]ccc7c6
SMILES	OpenEye OEToolkits	2.0.6	c1cc(nc(c1)C(=O)Nc2cc3c(cc2N4CCCCC4)oc(n3)N5CCOCC5)c6cc7cc[nH]c7nc6
Canonical SMILES	CACTVS	3.385	O=C(Nc1cc2nc(oc2cc1N3CCCCC3)N4CCOCC4)c5cccc(n5)c6cnc7[nH]ccc7c6
Canonical SMILES	OpenEye OEToolkits	2.0.6	c1cc(nc(c1)C(=O)Nc2cc3c(cc2N4CCCCC4)oc(n3)N5CCOCC5)c6cc7cc[nH]c7nc6
InChI	InChI	1.03	InChI=1S/C29H29N7O3/c37-28(22-6-4-5-21(32-22)20-15-19-7-8-30-27(19)31-18-20)33-23-16-24-26(17-25(23)35-9-2-1-3-10-35)39-29(34-24)36-11-13-38-14-12-36/h4-8,15-18H,1-3,9-14H2,(H,30,31)(H,33,37)
InChIKey	InChI	1.03	WDJXZWXJDHUFQZ-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	135121936

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.